These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20402384)

  • 1. Potential of mesenchymal stem cells for the therapy of autoimmune diseases.
    Pistoia V; Raffaghello L
    Expert Rev Clin Immunol; 2010 Mar; 6(2):211-8. PubMed ID: 20402384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory activity of mesenchymal stem cells.
    Kaplan JM; Youd ME; Lodie TA
    Curr Stem Cell Res Ther; 2011 Dec; 6(4):297-316. PubMed ID: 21190531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
    Rozier P; Maria A; Goulabchand R; Jorgensen C; Guilpain P; Noël D
    Front Immunol; 2018; 9():2938. PubMed ID: 30619298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9.
    Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L
    Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of the immunosuppressive properties of mesenchymal stromal cells.
    de Castro LL; Lopes-Pacheco M; Weiss DJ; Cruz FF; Rocco PRM
    J Mol Med (Berl); 2019 May; 97(5):605-618. PubMed ID: 30903229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection.
    Kassis I; Vaknin-Dembinsky A; Karussis D
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):63-8. PubMed ID: 20955154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.
    Ghannam S; Bouffi C; Djouad F; Jorgensen C; Noël D
    Stem Cell Res Ther; 2010 Mar; 1(1):2. PubMed ID: 20504283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications.
    Matheakakis A; Batsali A; Papadaki HA; Pontikoglou CG
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
    Ben-Ami E; Berrih-Aknin S; Miller A
    Autoimmun Rev; 2011 May; 10(7):410-5. PubMed ID: 21256250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for mesenchymal stem cells in autoimmune diseases?
    Uccelli A; Mancardi G; Chiesa S
    Autoimmunity; 2008 Dec; 41(8):592-5. PubMed ID: 18958745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells: a friend or foe in immune-mediated diseases.
    Gazdic M; Volarevic V; Arsenijevic N; Stojkovic M
    Stem Cell Rev Rep; 2015 Apr; 11(2):280-7. PubMed ID: 25592610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells; role in tissue repair, drug discovery and immune modulation.
    English K; Mahon BP; Wood KJ
    Curr Drug Deliv; 2014; 11(5):561-71. PubMed ID: 23517624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties and therapeutic application of mesenchymal stem cells.
    Shi M; Liu ZW; Wang FS
    Clin Exp Immunol; 2011 Apr; 164(1):1-8. PubMed ID: 21352202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.